Moolec Science and LightJump Acquisition announced the filing of a registration statement on Form F-4 by Moolec. The F-4 includes a preliminary proxy on the merger of the two companies in a deal valued at $504 million.
UK-based Moolec Sciences is engaged in molecular farming for the new food industry that uses plants to produce animal proteins.
At deal announcement in June, the combined company was expected to be funded with $138 million cash held in LightJump’s trust, assuming no redemptions and before payment of transaction expenses. In addition, LightJump has entered into a backstop agreement with entities affiliated with Moolec to guarantee a minimum of $10 million at closing.
The deal is expected to close by the end of the year. The SPAC’s deadline is Jan. 12. If approved, Moolec would list on the Nasdaq under the ticker symbol MLEC. Read more.
